UroGen Pharma reported total assets of $252.59M and total liabilities of $384.99M for the quarter ended Jun 2026, up 21.0% year over year. This balance sheet covers 39 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 55.34M | 44.36M | 105.38M | 80.69M | 28.69M | 55.41M | 36.54M | 20.13M | 119.31M | 95.00M | 131.44M | 219.97M | 124.92M | 171.99M | 104.03M | 92.90M | 90.04M | 110.75M | 109.97M | 79.13M | |||||||||||||||||||
| Short-term InvestmentsInvestments (Current) | 50.87M | 44.78M | 31.07M | 31.05M | 67.22M | 44.56M | 28.51M | 27.17M | 28.11M | 41.97M | 32.61M | 21.11M | 124.66M | 64.70M | 91.86M | 64.05M | 36.99M | 9.71M | 30.31M | 28.84M | |||||||||||||||||||
| Cash & Current Investments | 106.21M | 89.14M | 136.44M | 111.74M | 95.91M | 99.96M | 65.05M | 47.30M | 147.42M | 136.97M | 164.04M | 241.08M | 249.57M | 236.69M | 195.89M | 156.95M | 127.03M | 120.46M | 140.27M | 107.97M | |||||||||||||||||||
| Receivables - NetNet Receivables | 7.78M | 11.72M | 9.50M | 11.60M | 9.43M | 12.70M | 12.49M | 15.51M | 12.85M | 15.44M | 14.16M | 17.41M | 22.80M | 20.30M | 19.64M | 19.65M | 19.70M | 33.08M | 55.41M | 88.76M | |||||||||||||||||||
| Receivables | 7.78M | 11.72M | 9.50M | 11.60M | 9.43M | 12.70M | 12.49M | 15.51M | 12.85M | 15.44M | 14.16M | 17.41M | 22.80M | 20.30M | 19.64M | 19.65M | 19.70M | 33.08M | 55.41M | 88.76M | |||||||||||||||||||
| Raw Materials | |||||||||||||||||||||||||||||||||||||||
| Finished Goods | |||||||||||||||||||||||||||||||||||||||
| Inventory | 3.81M | 4.83M | 4.76M | 5.05M | 4.86M | 4.33M | 5.47M | 4.99M | 5.00M | 5.67M | 7.24M | 7.44M | 7.59M | 9.23M | 7.59M | 7.13M | 8.34M | 16.46M | 20.92M | 24.59M | |||||||||||||||||||
| Prepaid Assets | 6.11M | 7.48M | 9.28M | 10.43M | 10.58M | 11.10M | 12.15M | 12.72M | 16.04M | 10.28M | 10.49M | 12.21M | 14.05M | 8.85M | 12.98M | 12.05M | 12.12M | 14.67M | 19.53M | 12.78M | |||||||||||||||||||
| Current Assets | 125.14M | 114.39M | 160.52M | 139.62M | 121.59M | 128.91M | 95.97M | 81.33M | 182.12M | 169.19M | 196.76M | 278.97M | 295.10M | 276.13M | 237.18M | 196.87M | 168.55M | 186.02M | 237.46M | 235.43M | |||||||||||||||||||
| Non-Current Assets | |||||||||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 1.98M | 1.97M | 1.78M | 1.60M | 1.52M | 1.30M | 1.10M | 0.91M | 0.82M | 0.69M | 0.57M | 0.58M | 0.61M | 0.66M | 0.63M | 0.69M | 0.69M | 0.64M | 0.62M | 0.60M | |||||||||||||||||||
| Long-Term Investments | 4.07M | 0.68M | 0.67M | 0.67M | 0.22M | 0.22M | 10.16M | 7.97M | 6.51M | 4.50M | 0.48M | 0.20M | 4.64M | 5.02M | 4.51M | 4.63M | 0.38M | 0.18M | 0.18M | 0.18M | |||||||||||||||||||
| Long-Term Deferred Tax | 103.57M | 122.94M | 153.35M | ||||||||||||||||||||||||||||||||||||
| Other Non-Current Assets | 1.77M | 1.31M | 1.57M | 1.90M | 2.47M | 2.74M | 3.16M | 2.82M | 2.05M | 2.04M | 1.10M | 0.67M | 0.37M | 0.59M | 0.37M | 0.80M | 6.76M | 5.16M | 7.49M | 8.76M | |||||||||||||||||||
| Non-Current Assets | 9.46M | 5.36M | 5.19M | 6.52M | 6.88M | 6.71M | 16.98M | 14.03M | 11.51M | 9.12M | 3.81M | 2.88M | 6.85M | 9.58M | 10.44M | 11.85M | 16.50M | 14.43M | 16.23M | 17.16M | |||||||||||||||||||
| Assets | 134.60M | 119.75M | 165.72M | 146.14M | 128.47M | 135.62M | 112.95M | 95.36M | 193.63M | 178.31M | 200.57M | 281.85M | 301.94M | 285.71M | 247.62M | 208.72M | 185.05M | 200.46M | 253.69M | 252.59M | |||||||||||||||||||
| Liabilities | |||||||||||||||||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||||||||||||||||
| Accounts Payables | 11.06M | 12.10M | 9.94M | 8.65M | 9.36M | 12.38M | 17.13M | 16.40M | 14.08M | 16.54M | 18.16M | 23.75M | 19.68M | 27.43M | 30.32M | 30.96M | 26.17M | 27.72M | 35.35M | 39.95M | |||||||||||||||||||
| Payables | 11.06M | 12.10M | 9.94M | 8.65M | 9.36M | 12.38M | 17.13M | 16.40M | 14.08M | 16.54M | 18.16M | 23.75M | 19.68M | 27.43M | 30.32M | 30.96M | 26.17M | 27.72M | 35.35M | 39.95M | |||||||||||||||||||
| Accumulated Expenses | 6.48M | 6.95M | 5.15M | 6.43M | 6.62M | 8.26M | 4.92M | 6.72M | 8.15M | 10.81M | 4.99M | 6.85M | 9.03M | 10.57M | 6.97M | 11.65M | 11.11M | 13.52M | 9.84M | 12.25M | |||||||||||||||||||
| Other Accumulated Expenses | 2.27M | 3.33M | 4.01M | 2.96M | 3.02M | 3.28M | 3.19M | 3.64M | 3.55M | 3.86M | 3.20M | 3.62M | 4.07M | 7.95M | 4.71M | 4.94M | 4.96M | 3.43M | 5.45M | 7.62M | |||||||||||||||||||
| Current Leases | 1.27M | 1.41M | |||||||||||||||||||||||||||||||||||||
| Current Deferred Revenue | |||||||||||||||||||||||||||||||||||||||
| Total Current Liabilities | 19.81M | 22.38M | 19.09M | 18.04M | 19.00M | 23.92M | 25.23M | 26.77M | 25.79M | 31.21M | 26.34M | 34.22M | 32.79M | 45.95M | 42.00M | 47.55M | 42.24M | 46.42M | 50.63M | 61.91M | |||||||||||||||||||
| Non-Current Liabilities | |||||||||||||||||||||||||||||||||||||||
| Capital Leases | 3.48M | 2.94M | |||||||||||||||||||||||||||||||||||||
| Non-Current Debt | 70.80M | 71.20M | 71.87M | 97.54M | 97.94M | 98.30M | 98.52M | 98.55M | 97.59M | 97.81M | 121.71M | 121.73M | 122.11M | 122.51M | 122.11M | 122.21M | 189.53M | 188.73M | |||||||||||||||||||||
| Operating Leases | 0.62M | 0.40M | 1.21M | 2.33M | 2.80M | 2.53M | 2.37M | 2.12M | 1.88M | 0.84M | 1.42M | 1.22M | 1.04M | 1.65M | 2.84M | 3.41M | 6.24M | 2.65M | 5.65M | 3.04M | |||||||||||||||||||
| Other Non-Current Liabilities | 2.72M | 2.84M | 2.84M | 2.84M | 2.84M | 3.02M | 3.02M | 3.02M | 3.02M | 3.19M | 3.19M | 3.19M | 3.19M | 3.79M | 3.79M | 3.79M | 3.79M | 3.90M | 3.90M | 3.90M | |||||||||||||||||||
| Total Non-Current Liabilities | 100.35M | 108.49M | 179.95M | 184.21M | 188.92M | 221.96M | 226.49M | 230.78M | 232.61M | 240.33M | 237.51M | 248.34M | 273.23M | 290.72M | 290.29M | 298.30M | 296.66M | 302.03M | 374.04M | 381.08M | |||||||||||||||||||
| Total Liabilities | 103.07M | 111.33M | 182.79M | 187.05M | 191.76M | 224.98M | 229.51M | 233.79M | 235.63M | 243.52M | 240.71M | 251.53M | 276.43M | 294.51M | 294.08M | 302.09M | 300.45M | 305.93M | 377.94M | 384.99M | |||||||||||||||||||
| Shareholder's Equity | |||||||||||||||||||||||||||||||||||||||
| Total Debt | 70.80M | 71.20M | 71.87M | 97.54M | 97.94M | 98.30M | 98.52M | 98.55M | 97.59M | 97.81M | 121.71M | 121.73M | 122.11M | 122.51M | 122.11M | 122.21M | 189.53M | 188.73M | |||||||||||||||||||||
| Common Equity | 31.54M | 8.41M | -17.07M | -40.91M | -63.29M | -89.36M | -116.55M | -138.43M | 100.00M | -65.21M | -40.13M | 30.31M | 25.52M | -8.80M | -46.46M | -93.38M | -115.41M | -105.47M | -124.25M | -132.40M | |||||||||||||||||||
| Liabilities and Shareholders Equity | 134.60M | 119.75M | 165.72M | 146.14M | 128.47M | 135.62M | 112.95M | 95.36M | 193.63M | 178.31M | 200.57M | 281.85M | 301.94M | 285.71M | 247.62M | 208.72M | 185.05M | 200.46M | 253.69M | 252.59M | |||||||||||||||||||
| Retained Earnings | -438.90M | -467.32M | -495.71M | -522.40M | -548.24M | -577.10M | -607.32M | -631.50M | -653.33M | -679.35M | -711.63M | -745.04M | -768.71M | -806.22M | -850.10M | -900.00M | -933.40M | -959.72M | -983.30M | -997.64M | |||||||||||||||||||
| Preferred Shares |